You are here: Industry Insights > blood clot

News List

South Africa restarts inoculation with J&J’s Covid-19 vaccine pharmaceutical-technology
April 30, 2021
South Africa has resumed inoculation of health care workers with Johnson & Johnson’s (J&J) single-dose Covid-19 vaccine after a pause of over two weeks due to rare blood clot reports.
Joint CDC and FDA statement on Johnson & Johnson COVID-19 vaccine worldpharmanews
April 14, 2021
As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine have been administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after ...
US halts J&J COVID-19 vaccine after six women under 50 develop rare blood clots expresspharma
April 14, 2021
US federal health agencies recommended pausing the use of Johnson & Johnson’s COVID-19 vaccine after six women under 50 given the shot developed rare blood clots, dealing a fresh setback to efforts to tackle the pandemic.
EMA initiates review of J&J’s Covid-19 vaccine over blood clot reports pharmaceutical-technology
April 13, 2021
The European Medicines Agency (EMA) has initiated review of Johnson & Johnson’s (J&J) single-shot Covid-19 vaccine over reports of rare blood clots in four individuals in the US.
India to assess side effects of COVID-19 vaccine expresspharma
April 12, 2021
India is currently administering AstraZeneca's COVID-19 vaccine and a shot developed at home by Bharat Biotech.
No evidence of greater blood clot risk from vaccine: AstraZeneca expresspharma
March 16, 2021
Its review covered more than 17 million people vaccinated in the UK and EU and comes after health authorities in some countries suspended the use of its vaccine over clotting issues.
eXIthera Announces IND for EP-7041 Trial for COVID-19 Thrombosis Prevention americanpharmaceuticalreview
March 08, 2021
eXIthera Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application to initiate a Phase 2 clinical trial for EP-7041, a parenteral, potent, and selective small-molecule inhibitor ...
Researchers find new blood clot prevention strategy biospectrumasia
August 28, 2018
Medications such as anticoagulants are often provided during hospitalizations, but some clinicians and researchers feel these medications could be beneficial for medically ill patients for up to six weeks after hospital discharge when they remain at great